United States Radiopharmaceutical Market Report & Forecast 2021-2027

Publisher Name :
Date: 24-Sep-2021
No. of pages: 106
Inquire Before Buying

United States Radiopharmaceutical Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Radiopharmaceutical Market Segment Percentages, By Type, 2020 (%)

- Actinium-225

- Lutetium-177

- Radium-223

- Holmium-166

- Other

United States Radiopharmaceutical Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Radiopharmaceutical Market Segment Percentages, By Application, 2020 (%)

- Oncology

- Cardiology

- Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Radiopharmaceutical revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Radiopharmaceutical revenues share in United States market, 2020 (%)

Key companies Radiopharmaceutical sales in United States market, 2016-2021 (Estimated), (M Doses)

Key companies Radiopharmaceutical sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Bracco Imaging

- Bayer

- Mallinckrodt

- Nordion

- Triad Isotopes

- Lantheus

- IBA Group

- GE Healthcare

- China Isotope & Radiation

- Jubilant Pharma

- Eli Lilly

- Advanced Accelerator Applications

- SIEMENS

- Dongcheng

- Navidea

United States Radiopharmaceutical Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceutical Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Radiopharmaceutical Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Radiopharmaceutical Overall Market Size
2.1 United States Radiopharmaceutical Market Size: 2021 VS 2027
2.2 United States Radiopharmaceutical Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Radiopharmaceutical Sales: 2016-2027
3 Company Landscape
3.1 Top Radiopharmaceutical Players in United States Market
3.2 Top United States Radiopharmaceutical Companies Ranked by Revenue
3.3 United States Radiopharmaceutical Revenue by Companies
3.4 United States Radiopharmaceutical Sales by Companies
3.5 United States Radiopharmaceutical Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Radiopharmaceutical Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Radiopharmaceutical Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceutical Players in United States Market
3.8.1 List of Tier 1 Radiopharmaceutical Companies in United States
3.8.2 List of Tier 2 and Tier 3 Radiopharmaceutical Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Radiopharmaceutical Market Size Markets, 2021 & 2027
4.1.2 Actinium-225
4.1.3 Lutetium-177
4.1.4 Radium-223
4.1.5 Holmium-166
4.1.6 Other
4.2 By Type - United States Radiopharmaceutical Revenue & Forecasts
4.2.1 By Type - United States Radiopharmaceutical Revenue, 2016-2021
4.2.2 By Type - United States Radiopharmaceutical Revenue, 2022-2027
4.2.3 By Type - United States Radiopharmaceutical Revenue Market Share, 2016-2027
4.3 By Type - United States Radiopharmaceutical Sales & Forecasts
4.3.1 By Type - United States Radiopharmaceutical Sales, 2016-2021
4.3.2 By Type - United States Radiopharmaceutical Sales, 2022-2027
4.3.3 By Type - United States Radiopharmaceutical Sales Market Share, 2016-2027
4.4 By Type - United States Radiopharmaceutical Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Radiopharmaceutical Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - United States Radiopharmaceutical Revenue & Forecasts
5.2.1 By Application - United States Radiopharmaceutical Revenue, 2016-2021
5.2.2 By Application - United States Radiopharmaceutical Revenue, 2022-2027
5.2.3 By Application - United States Radiopharmaceutical Revenue Market Share, 2016-2027
5.3 By Application - United States Radiopharmaceutical Sales & Forecasts
5.3.1 By Application - United States Radiopharmaceutical Sales, 2016-2021
5.3.2 By Application - United States Radiopharmaceutical Sales, 2022-2027
5.3.3 By Application - United States Radiopharmaceutical Sales Market Share, 2016-2027
5.4 By Application - United States Radiopharmaceutical Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporation Information
6.1.2 Bracco Imaging Overview
6.1.3 Bracco Imaging Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.1.4 Bracco Imaging Radiopharmaceutical Product Description
6.1.5 Bracco Imaging Recent Developments
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Overview
6.2.3 Bayer Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.2.4 Bayer Radiopharmaceutical Product Description
6.2.5 Bayer Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Overview
6.3.3 Mallinckrodt Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.3.4 Mallinckrodt Radiopharmaceutical Product Description
6.3.5 Mallinckrodt Recent Developments
6.4 Nordion
6.4.1 Nordion Corporation Information
6.4.2 Nordion Overview
6.4.3 Nordion Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.4.4 Nordion Radiopharmaceutical Product Description
6.4.5 Nordion Recent Developments
6.5 Triad Isotopes
6.5.1 Triad Isotopes Corporation Information
6.5.2 Triad Isotopes Overview
6.5.3 Triad Isotopes Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.5.4 Triad Isotopes Radiopharmaceutical Product Description
6.5.5 Triad Isotopes Recent Developments
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Overview
6.6.3 Lantheus Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.6.4 Lantheus Radiopharmaceutical Product Description
6.6.5 Lantheus Recent Developments
6.7 IBA Group
6.7.1 IBA Group Corporation Information
6.7.2 IBA Group Overview
6.7.3 IBA Group Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.7.4 IBA Group Radiopharmaceutical Product Description
6.7.5 IBA Group Recent Developments
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Overview
6.8.3 GE Healthcare Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.8.4 GE Healthcare Radiopharmaceutical Product Description
6.8.5 GE Healthcare Recent Developments
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Corporation Information
6.9.2 China Isotope & Radiation Overview
6.9.3 China Isotope & Radiation Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.9.4 China Isotope & Radiation Radiopharmaceutical Product Description
6.9.5 China Isotope & Radiation Recent Developments
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Corporation Information
6.10.2 Jubilant Pharma Overview
6.10.3 Jubilant Pharma Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.10.4 Jubilant Pharma Radiopharmaceutical Product Description
6.10.5 Jubilant Pharma Recent Developments
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Overview
6.11.3 Eli Lilly Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.11.4 Eli Lilly Radiopharmaceutical Product Description
6.11.5 Eli Lilly Recent Developments
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Corporation Information
6.12.2 Advanced Accelerator Applications Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Description
6.12.5 Advanced Accelerator Applications Recent Developments
6.13 SIEMENS
6.13.1 SIEMENS Corporation Information
6.13.2 SIEMENS Overview
6.13.3 SIEMENS Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.13.4 SIEMENS Radiopharmaceutical Product Description
6.13.5 SIEMENS Recent Developments
6.14 Dongcheng
6.14.1 Dongcheng Corporation Information
6.14.2 Dongcheng Overview
6.14.3 Dongcheng Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.14.4 Dongcheng Radiopharmaceutical Product Description
6.14.5 Dongcheng Recent Developments
6.15 Navidea
6.15.1 Navidea Corporation Information
6.15.2 Navidea Overview
6.15.3 Navidea Radiopharmaceutical Sales and Revenue in United States Market (2016-2021)
6.15.4 Navidea Radiopharmaceutical Product Description
6.15.5 Navidea Recent Developments
7 United States Radiopharmaceutical Production Capacity, Analysis
7.1 United States Radiopharmaceutical Production Capacity, 2016-2027
7.2 Radiopharmaceutical Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Radiopharmaceutical Supply Chain Analysis
9.1 Radiopharmaceutical Industry Value Chain
9.2 Radiopharmaceutical Upstream Market
9.3 Radiopharmaceutical Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Radiopharmaceutical Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Radiopharmaceutical in United States Market
Table 2. Top Radiopharmaceutical Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Radiopharmaceutical Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Radiopharmaceutical Revenue Share by Companies, 2016-2021
Table 5. United States Radiopharmaceutical Sales by Companies, (M Doses), 2016-2021
Table 6. United States Radiopharmaceutical Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Radiopharmaceutical Price (2016-2021) & (USD/Dose)
Table 8. Manufacturers Radiopharmaceutical Product Type
Table 9. List of Tier 1 Radiopharmaceutical Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Radiopharmaceutical Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Actinium-225
Table 12. Major Manufacturers of Lutetium-177
Table 13. By Type - United States Radiopharmaceutical Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Radiopharmaceutical Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Radiopharmaceutical Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Radiopharmaceutical Sales (M Doses), 2016-2021
Table 17. By Type - United States Radiopharmaceutical Sales (M Doses), 2022-2027
Table 18. By Application - United States Radiopharmaceutical Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Radiopharmaceutical Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Radiopharmaceutical Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Radiopharmaceutical Sales (M Doses), 2016-2021
Table 22. By Application - United States Radiopharmaceutical Sales (M Doses), 2022-2027
Table 23. Bracco Imaging Corporation Information
Table 24. Bracco Imaging Description and Major Businesses
Table 25. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 26. Bracco Imaging Radiopharmaceutical Product
Table 27. Bracco Imaging Recent Developments
Table 28. Bayer Corporation Information
Table 29. Bayer Description and Major Businesses
Table 30. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 31. Bayer Radiopharmaceutical Product
Table 32. Bayer Recent Developments
Table 33. Mallinckrodt Corporation Information
Table 34. Mallinckrodt Description and Major Businesses
Table 35. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 36. Mallinckrodt Radiopharmaceutical Product
Table 37. Mallinckrodt Recent Developments
Table 38. Nordion Corporation Information
Table 39. Nordion Description and Major Businesses
Table 40. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 41. Nordion Radiopharmaceutical Product
Table 42. Nordion Recent Developments
Table 43. Triad Isotopes Corporation Information
Table 44. Triad Isotopes Description and Major Businesses
Table 45. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 46. Triad Isotopes Radiopharmaceutical Product
Table 47. Triad Isotopes Recent Developments
Table 48. Lantheus Corporation Information
Table 49. Lantheus Description and Major Businesses
Table 50. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 51. Lantheus Radiopharmaceutical Product
Table 52. Lantheus Recent Developments
Table 53. IBA Group Corporation Information
Table 54. IBA Group Description and Major Businesses
Table 55. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 56. IBA Group Radiopharmaceutical Product
Table 57. IBA Group Recent Developments
Table 58. GE Healthcare Corporation Information
Table 59. GE Healthcare Description and Major Businesses
Table 60. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 61. GE Healthcare Radiopharmaceutical Product
Table 62. GE Healthcare Recent Developments
Table 63. China Isotope & Radiation Corporation Information
Table 64. China Isotope & Radiation Description and Major Businesses
Table 65. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 66. China Isotope & Radiation Radiopharmaceutical Product
Table 67. China Isotope & Radiation Recent Developments
Table 68. Jubilant Pharma Corporation Information
Table 69. Jubilant Pharma Description and Major Businesses
Table 70. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 71. Jubilant Pharma Radiopharmaceutical Product
Table 72. Jubilant Pharma Recent Developments
Table 73. Eli Lilly Corporation Information
Table 74. Eli Lilly Description and Major Businesses
Table 75. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 76. Eli Lilly Radiopharmaceutical Product
Table 77. Eli Lilly Recent Developments
Table 78. Advanced Accelerator Applications Corporation Information
Table 79. Advanced Accelerator Applications Description and Major Businesses
Table 80. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 81. Advanced Accelerator Applications Radiopharmaceutical Product
Table 82. Advanced Accelerator Applications Recent Developments
Table 83. SIEMENS Corporation Information
Table 84. SIEMENS Description and Major Businesses
Table 85. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 86. SIEMENS Radiopharmaceutical Product
Table 87. SIEMENS Recent Developments
Table 88. Dongcheng Corporation Information
Table 89. Dongcheng Description and Major Businesses
Table 90. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 91. Dongcheng Radiopharmaceutical Product
Table 92. Dongcheng Recent Developments
Table 93. Navidea Corporation Information
Table 94. Navidea Description and Major Businesses
Table 95. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 96. Navidea Radiopharmaceutical Product
Table 97. Navidea Recent Developments
Table 98. Radiopharmaceutical Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 99. United States Radiopharmaceutical Capacity Market Share of Key Manufacturers, 2019-2021
Table 100. Radiopharmaceutical Market Opportunities & Trends in United States Market
Table 101. Radiopharmaceutical Market Drivers in United States Market
Table 102. Radiopharmaceutical Market Restraints in United States Market
Table 103. Radiopharmaceutical Raw Materials
Table 104. Radiopharmaceutical Raw Materials Suppliers in United States Market
Table 105. Typical Radiopharmaceutical Downstream
Table 106. Radiopharmaceutical Downstream Clients in United States Market
Table 107. Radiopharmaceutical Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Radiopharmaceutical Segment by Type
Figure 3. Radiopharmaceutical Segment by Application
Figure 4. United States Radiopharmaceutical Market Overview: 2020
Figure 5. United States Radiopharmaceutical Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Radiopharmaceutical Revenue, 2016-2027 (US$, Mn)
Figure 7. Radiopharmaceutical Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Radiopharmaceutical Revenue in 2020
Figure 9. Actinium-225 Product Picture
Figure 10. Lutetium-177 Product Picture
Figure 11. Radium-223 Product Picture
Figure 12. Holmium-166 Product Picture
Figure 13. Other Product Picture
Figure 14. By Type - United States Radiopharmaceutical Sales Market Share, 2016-2027
Figure 15. By Type - United States Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 16. By Type - United States Radiopharmaceutical Price (USD/Dose), 2016-2027
Figure 17. Oncology
Figure 18. Cardiology
Figure 19. Other
Figure 20. By Application - United States Radiopharmaceutical Sales Market Share, 2016-2027
Figure 21. By Application - United States Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 22. By Application - United States Radiopharmaceutical Price (USD/Dose), 2016-2027
Figure 23. Bracco Imaging Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Bayer Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Mallinckrodt Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Nordion Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Triad Isotopes Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Lantheus Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. IBA Group Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. GE Healthcare Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. China Isotope & Radiation Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Jubilant Pharma Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Eli Lilly Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Advanced Accelerator Applications Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. SIEMENS Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Dongcheng Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Navidea Radiopharmaceutical Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. United States Radiopharmaceutical Production Capacity (M Doses), 2016-2027
Figure 39. Radiopharmaceutical Industry Value Chain
Figure 40. Marketing Channels
  • Global Radiopharmaceutical Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......
  • Global Radiopharmaceuticals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......
  • Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137
    According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......
  • Global Radiation Dose Management Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......
  • Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......
  • Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......
  • Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133
    Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
  • Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
  • Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs